The effect of long-term, non-suppressive levothyroxine treatment on quantitative ultrasonometry of bone in women

European Journal of Endocrinology

Volumn 142, Issue 5, 2000, Pages 445-450

  Hadji, Peyman ^a   Hars, Olaf ^b   Sturm, Gerhard ^a   Bauer, Thomas ^a   Emons, Günter ^a   Schulz, Klaus Dieter ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE;

ADULT; AGED; ARTICLE; BONE ATROPHY; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; GOITER; HIP FRACTURE; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; OSTEOPOROSIS; PATHOGENESIS; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RISK FACTOR;

EID: 0034048063     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1420445     Document Type: Article

References (51)

1. Kanis JA, Devogelaer JP & Gennari C. Practical guide for the use of bone mineral measurements in the assessment of treatment of osteoporosis: a position paper of the European Foundation for Osteoporosis and Bone Disease. Osteoporosis International 1996 6 256-261.
2. Bauer DC, Nevitt MC, Ettinger B & Stone K. Low thyrotropin levels are not associated with hone loss in older women: a prospective study. Journal of Clinical Endocrinology and Metabolism 1997 82 2931-2936.
3. Uzzan B, Campos J, Cucherat M, Nony P, Boissel JP & Perret GY. Effects on bone mass of long-term treatment with thyroid hormones: a meta-analysis. Journal of Clinical Endocrinology and Metabolism 1996 81 4278-4289.
4. Mosekilde L, Eriksen EF & Charles P. Effects of thyroid hormones on bone and mineral metabolism. Endocrinology and Metabolism Clinics of North America 1990 19 35-65.
5. Mosekilde L, Melsen F, Bagger JP, Myhere-Jensen O & Sorensen NS. Bone changes in hyperthyroidism. Interrelationship between hone morphometry, thyroid function and calcium-phosphorus metabolism. Acta Endocrinologica 1977 85 515-525.
6. Wartofsky L. Osteoporosis: a growing concern for the thyroidologist. Thyroid Today 1988 111-11.
7. Auwerx J & Bouillon R. Mineral and bone metabolism in thyroid disease: a review. Quarterly Journal of Medicine 1986 60 737-752.
8. Baran DT & Braverman LE. Editorial: thyroid hormones and bone mass. Journal of Clinical Endocrinology and Metabolism 1991 72 1182-1183.
9. Wüster C, Schilddrüse und Osteoporose. In Schilddrüse 1993: Therapie der Hyperthyreose, pp 380-392. Eds D Reinwein & B Weinheimer. Berlin. New York: DeGryter, 1994.
10. Ross DS, Neer RM, Ridgway EC & Daniels GH. Subclinical hyperthyroidism and reduced hone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine. American Journal of Medicine 1987 82 1167-1170.
11. Paul TL, Kerrigan J, Kelly AM, Braverman LE & Baran DT. Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal women. JAMA 1988 259 3137-3141.
12. Taelman P, Kaufman JM, Janssens X, Vandecauter H & Vermeulen A. Reduced forearm bone mineral content and biochemical evidence of increased bone turnover in women with euthyroid goitre treated with thyroid hormone. Clinical Endocrinology 1990 33 107-117.
13. Diamond T, Nery L & Hales I. A therapeutic dilemma: suppressive doses of thyroxine significantly reduce bone mineral measurements in both premenopausal and postmenopausal women with thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 1990 72 1184-1188.
14. Guo CY, Weetman P & Eastell R. Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine. Clinical Endocrinology 1997 46 301-307.
15. Hawkins F, Rigopoulou D, Papapietro K & Lopez MB. Spinal bone mass after long-term treatment with l-thyroxine in postmenopausal women with thyroid cancer and chronic lymphocytic thyroiditis. Calcified Tissue International 1994 54 16-19.
16. Nuzzo V, Lupoli G, Del Puente A, Rampone E, Carpinelli A, Esposito Del Puente A et al. Bone mineral density in premenopausal women receiving levothyroxine suppressive therapy. Gynecology and Endocrinology 1998 12 333-337.
17. Müller CG, Bayley TA, Harrison JE & Tsang R. Possible limited bone loss with suppressive thyroxine therapy is unlikely to have clinical relevance. Thyroid 1995 5 81-87.
18. Leese GP, Jung RT, Guthrie C, Waugh N & Browning MC. Morbidity in patients on L-thyroxine: a comparison of those with a normal to those with a suppressed TSH. Clinical Endocrinology 1992 37 500-503.
19. Salomon BL, Wartofsky L & Burman KD. Prevalence of fractures in postmenopausal women with thyroid disease. Thyroid 1993 3 17-23.
20. Kung AWC & Pun KK. Bone mineral density in premenopausal women receiving long-term physiological doses of thyroxine. JAMA 1991 265 2688-2691.
21. Grant DJ, McMurdo MET, Mole PA, Paterson CR & Davies RR. Suppressed TSH levels secondary to thyroxine replacement therapy are not associated with osteoporosis. Clinical Endocrinology 1993 59 529-533.
22. Schneider DL, Barrett-Connor EL & Morton DJ. Thyroid hormone use and bone mineral density in elderly women. Effects of estrogen. JAMA 1994 271 1245-1249.
23. Franklyn JA, Betteridge J, Dykin J, Holder R, Oates G. Parle JV et al. Long-term thyroxine treatment and bone mineral density. Lancet 1992 340 9-13.
24. Hans D, Schott AM & Meunier PJ. Ultrasonic assessment of bone: a review. European Journal of Medicine 1993 2 157-163.
25. Gluer CC. Quantitative ultrasound techniques for the assessment of osteoporosis: expert agreement on current status. Journal of Bone and Mineral Research 1997 12 1280-1288.
26. Wüster C, Heilmann P, Pereira-Lima J, Schlegel J, Anstätt K & Soballa T. Quantitative ultrasonometry (QUS) for the evaluation of osteoporosis risk: reference data for various measurement sites, limitations and application possiblities. Experimental and Clinical Endocrinology and Diabetes 1998 106 277-288.
27. Kang C & Speller R. Comparison of ultrasound and dual energy X-ray absorptiometry measurements in the calcaneus. British Journal of Radiology 1998 71 861-867.
28. Greenspan SL, Bouxsein ML, Melton ME, Kolodny AH, Clair JH, Delucca PT et al. Precision and discriminatory ability of calcancal bone assessment technologies. Journal of Bone and Mineral Research 1997 12 1303-1313.
29. Zerahn B, Borgwardt A, Hejsgard C & Lemser T. Ultrasound and BMD measurements of the os calcis in normal Danish adults. European Journal of Experimental Musculoskeletal Research 1996 4 154-159.
30. Han S, Medige J, Faran K, Feng Z & Ziv I. The ability of quantitative ultrasound to predict the mechanical properties of trabecular bone under different strain rates. Medical Engineering and Physics 1997 9 742-747.
31. Hodgskinson R, Njeh CF, Currey JD & Langton CM. The ability of ultrasound velocity to predict the stiffness of cancellous bone in vitro. Bone 1997 21 183-190.
32. Cheng S, Tylavsky F & Carbone L. Utility of ultrasound to assess risk of fracture. Journal of American Geriatric Society 1997 45 1382-1394.
33. Gregg EW, Kriska AM, Salamone LM, Roberts MM, Anderson SJ. Ferrell RE et al. The epidemiology of quantitative ultrasound: a review of the relationships with bone mass, osteoporosis and fracture risk. Osteoporosis International 1997 7 89-99.
34. Hans D, Dargent-Molina P, Schott AM, Sebert JL, Cormier C, Kotzki PO et al. Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study. Lancet 1996 348 511-514.
35. Bauer DC, Gluer CC, Caulcy JA, Vogt TM, Ensrud KE, Genant HK et al. Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women. Archives of Internal Medicine 1947 157 629-634.
36. Schott AM, Weill-Engerer S, Hans D, Duboeuf F, Delmas PD & Meunier PJ. Ultrasound discriminates patients with hip fracture equally well as dual energy X-ray absorptiometry and independently of bone mineral density. Journal of Bone and Mineral Research 1995 10 243-249.
37. Cepollaro C, Gonnelli S, Pondrelli C, Martini S, Montagnani A, Rossi S et al. The combined use of ultrasound and densitometry in the prediction of vertebral fracture. British Journal of Radiology 1997 70 691-686.
38. Turner CH, Peacock M, Timmerman L, Neal JM & Johnston CC Jr. Calcaneal ultrasonic measurements discriminate hip fracture independently of bone mass. Osteoporosis International 1995 5 130-135.
39. Gomez Acotto C, Schott AM, Hans D, Niepomniszcze H, Mautalen CA & Meunier PJ. Hyperthyroidism influences ultrasound bone measurement on the on calcis. Ostroporosis International 1998 8 455-459.
40. Gomez Acotto C, Schott AM, Hans D, Niepomniszeze H, Mautalen CA & Meunier PJH. Recovery of bone mass in treated hyperthyroidism. Bone 1998 22 701.
41. Rosen CJ & Adler RA. Longitudinal changes in lumbar bone density among thyrotoxic patients after attainment of euthyroidism. Journal of Clinical Endocrinology and Metabolism 1992 75 1531-1534.
42. Eriksen EF, Mosekilde L & Melsen F. Trabecular bone remodeling and bone balance in hyperthyroidism. Bone 1985 6 421-426.
43. Kragstrup J, Melsen F & Mosekilde L. Effects of thyroid hormones on mean wall thickness of trabecular bone packets. Metabolic Bone Disease Related Research 1981 3 181-186.
44. Mosekilde L & Melsen E. Morphometric and dynamic studies of bone changes in hypothyroidism. Acta Pathologica et Microbiologica Scandinavica 1978 86 56-62.
45. De Rosa G, Testa A, Giacomini D, Carrozza C, Astazi P & Caradonna P. Prospective study of bone loss in pre-and post-menopausal women on L-thyroxine therapy for non-toxic goitre. Clinical Endocrinology 1997 47 529-535.
46. Lehmke J, Bogner U, Felsenberg D, Peters H & Schleusener H. Determination of bone mineral density by quantitative computed tomography and single photon absorptiometry in subclinical hyperthyroidism: a risk of early osteopaenia in post-menopausal women. Clinical Endocrinology 1992 36 511-517.
47. Faber J & Galloe AM. Changes In bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a metaanalysis. European Journal of Endocrinology 1994 130 350-356.
48. Marcocci C, Colla F, Bruno-Bossio G, Vignali E & Pinchera A. Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women. Journal of Clinical Endocrinology and Metabolism 1994 78 818-823.
49. Langdahl BL, Loft AG, Moller N, Weeke J, Eriksen EF, Mosekilde L et al. Skeletal responsiveness to thyroid hormone is not altered at menopause. Bone 1996 19 557-564.
50. Hanna FWF, Pettit RJ, Ammari F, Evans WD, Sandeman D & Lazarus JH. Effect of replacement doses of thyroxine on bone mineral density. Clinical Endocrinology 1998 48 229-234.
51. Saggese G, Bertelloni S, Baroncelli GI, Costa S & Ceccarelli C. Bone mineral density in adolescent females treated with L-thyroxine: a longitudinal study. European Journal of Pediatrics 1996 155 452-457.